According to Novocure 's latest financial reports the company's total liabilities are $0.78 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.78 B | 4.42% |
2022-12-31 | $0.75 B | 2.95% |
2021-12-31 | $0.72 B | 26.68% |
2020-12-31 | $0.57 B | 119.93% |
2019-12-31 | $0.26 B | 15% |
2018-12-31 | $0.22 B | 49.96% |
2017-12-31 | $0.15 B | 8.59% |
2016-12-31 | $0.13 B | 147.25% |
2015-12-31 | $56.51 M | 182.57% |
2014-12-31 | $20 M | 16.75% |
2013-12-31 | $17.13 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $2.69 M | -99.66% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.12 B | -84.43% | ๐ฌ๐ง UK |
Novavax NVAX | $2.51 B | 220.87% | ๐บ๐ธ USA |
Novocure
NVCR | $0.78 B | 0.00% | Jersey |